Skip to main content
Caplight Logo









Biobase

Biobase

Private
San Diego, CaliforniaAI, Data & Cloud Infrastructurehttps://www.biobase.ai/

Last Round

Pre Seed

Jul 8, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biobase is a healthcare technology company that provides an AI-powered, federated operating system for clinical data to connect healthcare providers with life sciences and research organizations.

Sector

AI, Data & Cloud Infrastructure

Verticals

Database Management, Cloud Infrastructure, Platform-as-a-Service, Serverless Computing, Identity & Access

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Infrastructure

Keywords

backend-as-a-serviceBaaSPostgreSQLfirebase alternativeserverless backendvector databaseedge functionsreal-time databaseopen-source backendauthentication serviceobject storagedeveloper platformclinical data platformagentic ai

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biobase Comparables

Compare Biobase with similar companies based on industry and business-model similarity.

Biobase comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TileDB
38%
ThinkBio.Ai, Inc.
35%
Avandra Imaging
34%

Biobase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 8, 2026
StrategicJan 22, 2026

Key People

Founding team and executive leadership

Terence O'Keeffe

Co-Founder & COO

Founding Team

Todd Parker

Co-Founder & CEO

Founding Team

Jonathan Maddison

Chief Technology Officer

Executive Team

Andreas Matthes

Fractional CFO

Executive Team

Biobase Investors

Notable investors and investment history

Biobase investors
InvestorRounds
DigiTx PartnersPre Seed
Nina CapitalPre Seed
Washington Research Foundation CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 8, 2026

    Secured funding from DigiTx Partners, Nina Capital, and WRF Capital.

  • Jan 22, 2026

    BJC Health System participated in the round.

Biobase Filings

Explore SEC and related filing metadata, where available.

Biobase filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biobase's valuation, stock price, and market status.

Is Biobase a public or private company?

Biobase is a private company.

What is the current stock price of Biobase?

Biobase is a private company with no public stock price. No recent secondary market data is available.

How much is Biobase worth (valuation)?

Valuation information for Biobase is not publicly available.

Can I buy Biobase stock?

Biobase shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biobase's last funding round?

Biobase's most recent funding round was Pre Seed on July 8, 2026.

Who are the main investors in Biobase?

Key investors in Biobase include DigiTx Partners, Nina Capital, Washington Research Foundation Capital.

Will Biobase IPO soon?

No public IPO plans have been announced for Biobase.

How can I track Biobase secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biobase's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range9
Year Founded2025
Last FundingJul 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?